Visionary Ventures
Visionary Ventures is a venture capital fund investing in life sciences, ophthalmology, and medical aesthetics. They focus on early and late-stage investments, from Series A rounds through commercialization, with a target investment range of $5M to $15M. Their unique approach leverages partnerships with Key Opinion Leaders (KOLs) to enhance investment insights and reduce risk.
📥 Buy Full VC Dataset
Offices: Newport Beach (United States)
Investment Stages: Series A, Series B
Markets: Ophthalmology, Medical Aesthetics, Life Sciences
Founded Year: 2016
Investor Type: Venture Capital
Portfolio Companies: Aurion Biotech, Centricity Vision, CorneaGen, IanTech, IanTrek, Inc., ONL Therapeutics, Orasis, Pelage Pharmaceuticals, Re-Vana Therapeutics, RxSight, Surface Pharmaceuticals, Sydnexis, Tarsus Pharmaceuticals, Tear Film Innovations, TearClear
Website: https://visionaryvc.com
Team Page: https://visionaryvc.com/meet-the-visionary-team/
Portfolio Link: https://visionaryvc.com/portfolio/
LinkedIn: https://www.linkedin.com/company/visionary-ventures-fund
Crunchbase: https://www.crunchbase.com/organization/visionary-venture-fund
Comments
No comments yet. Be the first to comment!